Difference between revisions of "DZI19-174-Case-7"
From MGH Learn Pathology
(PGY1 set) |
|||
Line 1: | Line 1: | ||
{{dziCase | {{dziCase | ||
− | |||
− | |||
|dziorder=DZI19-174 | |dziorder=DZI19-174 | ||
− | |case_id= | + | |case_id=D6-1 |
− | |||
|clinical_hx=Prophylactic mastectomy in a 49 y/o female with family history of breast cancer and with a BRCA2 mutation. | |clinical_hx=Prophylactic mastectomy in a 49 y/o female with family history of breast cancer and with a BRCA2 mutation. | ||
− | |case_diagnosis=Ductal carcinoma in situ with neuroendocrine features. | + | |case_diagnosis=Ductal carcinoma in situ with neuroendocrine features. |
}} | }} | ||
− | {{ | + | {{dziSlide |
− | | | + | |dziorder=DZI19-174 |
− | | | + | |slide_id=7 |
− | |||
|slide_stain=H&E | |slide_stain=H&E | ||
− | | | + | |dzi_filename=DZI19-174-Case-7_1 |
}} | }} | ||
− | {{ | + | {{dziSlide |
− | | | + | |dziorder=DZI19-174 |
− | | | + | |slide_id=7 |
− | + | |slide_stain=Chromogranin A | |
− | |slide_stain=Chromogranin | + | |dzi_filename=DZI19-174-Case-7_2 |
− | | | ||
}} | }} | ||
− | {{ | + | {{dziSlide |
− | | | + | |dziorder=DZI19-174 |
− | | | + | |slide_id=7 |
− | |||
|slide_stain=Synapto (PNC) B5 | |slide_stain=Synapto (PNC) B5 | ||
− | | | + | |dzi_filename=DZI19-174-Case-7_3 |
}} | }} | ||
− | {{ | + | {{dziSlide |
− | | | + | |dziorder=DZI19-174 |
− | | | + | |slide_id=7 |
− | |||
|slide_stain=Keratin 5/6 (MT1) B4 | |slide_stain=Keratin 5/6 (MT1) B4 | ||
− | | | + | |dzi_filename=DZI19-174-Case-7_4 |
}} | }} | ||
− | {{ | + | {{dziSlide |
− | | | + | |dziorder=DZI19-174 |
− | | | + | |slide_id=7 |
− | |||
|slide_stain=E Cadherin (T-C) B7 | |slide_stain=E Cadherin (T-C) B7 | ||
− | | | + | |dzi_filename=DZI19-174-Case-7_5 |
}} | }} |
Revision as of 08:16, November 1, 2021
No results
No resultsNo results
No resultsNo results